Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

for
Colorectal Polyp, Colorectal Neoplasms, Colorectal Adenoma,
Location: Lebanon NH, New York NY, Washington D.C. DC,
Sponsor: Dartmouth-Hitchcock Medical Center

Sex: All

Age: 65 - 70+

Code: NCT05612347

Recruiting

A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

for
Advanced NRAS-Mutant Melanoma,
Location: Boston MA, New York NY, Fairfax VA, Grand Rapids MI,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07584226

Phase 1, Phase 2, Recruiting

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors

for
Brain and Central Nervous System Tumors, Metastatic Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 3 - 70

Code: NCT00002647

Phase 1, Recruiting

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

for
Acquired Immunodeficiency Syndrome, BK Virus Infection,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT02479698

Phase 2, Recruiting

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

for
Adenocarcinoma, Basal Cell Carcinoma, Squamous Cell Carcinoma,
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT07628634

Early Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

for
Solid Tumor, Melanoma, HNSCC, Sarcoma, Squamous Cell Carcinoma,
Location: Boston MA, Fairfax VA, Pittsburgh PA, Dallas TX
Sponsor: ImmVira Pharma Co. Ltd

Sex: All

Age: 18+

Code: NCT04370587

Phase 1, Phase 2, Recruiting

ALIGN for Older Adults With Cancer in SNFs

for
Advanced Cancer
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT06616298

Recruiting

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

for
PIK3CA Mutations, Advanced Solid Tumors, Adult,
Location: Boston MA, East Brunswick NJ, Fairfax VA, Tampa FL,
Sponsor: Cogent Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07383506

Phase 1, Recruiting

Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)

for
Solid Tumor Malignancies, Testicular Cancer,
Location: Tucson AZ
Sponsor: University of Arizona

Sex: All

Age: 18+

Code: NCT07407582

Phase 1, Phase 2, Recruiting

Collection of Tissue Samples for Cancer Research

for
Neoplasms, Lymphomas, Multiple Myeloma,
Location: Baltimore MD, Bethesda MD, Buffalo NY, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT00900198

Recruiting

EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors

for
Advanced Solid Tumor, Homologous Recombination Deficiency,
Location: Durham NC, Shreveport LA, Houston TX, Seattle WA
Sponsor: Eisbach Bio GmbH

Sex: All

Age: 18+

Code: NCT06525298

Phase 1, Phase 2, Recruiting

Patient Navigation to Improve Patient-Centered Cancer Care

for
Cancer
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT03226405

Recruiting

Durvalumab and Oleclumab in Resectable PDAC

for
Pancreatic Ductal Adenocarcinoma
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06060405

Phase 2, Recruiting

Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting

for
Infertility, Male, Cancer, Autoimmune Disorder
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: Male

Age: 0+

Code: NCT04452305

Recruiting

(Peak) A Phase 3 Randomized Trial of Bezuclastinib (CGT9486)+Sunitinib vs. Sunitinib in Participants With Gastrointestinal Stromal Tumors

for
Advanced Gastrointestinal Stromal Tumors, Metastatic Cancer
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Cogent Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05208047

Phase 3, Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

for
Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Location: Boston MA, Providence RI, Norwalk CT, New York NY,
Sponsor: Fore Biotherapeutics

Sex: All

Age: 8+

Code: NCT05503797

Phase 2, Recruiting

SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization

for
Prostate Cancer, Advanced Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18 - 70+

Code: NCT06389097

Recruiting

Trial of Spiritual Care Interventions for Patients With Cancer

for
Advanced Cancer
Location: New York NY, Galveston TX, Houston TX
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18+

Code: NCT07408310

Recruiting

Improving Cognition and Behavior in Pediatric Cancer Survivors Using a Novel Mindful Attention Training

for
Pediatric Cancer
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 7 - 17

Code: NCT05000905

Recruiting

Phase 1/2 Study of UI-102 in Selected Advanced Cancers

for
Advanced Cancer
Location: Houston TX, Dallas TX, San Antonio TX
Sponsor: United Immunity, co., Ltd.

Sex: All

Age: 18+

Code: NCT07605962

Phase 1, Phase 2, Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial